nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP11A1—Dexamethasone—ankylosing spondylitis	0.302	0.311	CbGbCtD
Aminoglutethimide—CYP19A1—Betamethasone—ankylosing spondylitis	0.242	0.249	CbGbCtD
Aminoglutethimide—CYP19A1—Dexamethasone—ankylosing spondylitis	0.141	0.145	CbGbCtD
Aminoglutethimide—CYP2C19—Prednisone—ankylosing spondylitis	0.059	0.0608	CbGbCtD
Aminoglutethimide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0471	0.0485	CbGbCtD
Aminoglutethimide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0369	0.038	CbGbCtD
Aminoglutethimide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0357	0.0368	CbGbCtD
Aminoglutethimide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0306	0.0316	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0302	0.0311	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisone—ankylosing spondylitis	0.0285	0.0294	CbGbCtD
Aminoglutethimide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0178	0.0184	CbGbCtD
Aminoglutethimide—Adrenal insufficiency—Prednisone—ankylosing spondylitis	0.00245	0.0825	CcSEcCtD
Aminoglutethimide—Alveolitis allergic—Methotrexate—ankylosing spondylitis	0.00164	0.0553	CcSEcCtD
Aminoglutethimide—Hirsutism—Prednisolone—ankylosing spondylitis	0.00122	0.0409	CcSEcCtD
Aminoglutethimide—Haematocrit decreased—Methotrexate—ankylosing spondylitis	0.00115	0.0388	CcSEcCtD
Aminoglutethimide—Hirsutism—Triamcinolone—ankylosing spondylitis	0.00112	0.0376	CcSEcCtD
Aminoglutethimide—Hirsutism—Methylprednisolone—ankylosing spondylitis	0.00112	0.0375	CcSEcCtD
Aminoglutethimide—Hirsutism—Dexamethasone—ankylosing spondylitis	0.00101	0.0341	CcSEcCtD
Aminoglutethimide—Hirsutism—Betamethasone—ankylosing spondylitis	0.00101	0.0341	CcSEcCtD
Aminoglutethimide—Hirsutism—Prednisone—ankylosing spondylitis	0.000884	0.0297	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Prednisone—ankylosing spondylitis	0.0008	0.0269	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.000556	0.0187	CcSEcCtD
Aminoglutethimide—Neutropenia—Prednisone—ankylosing spondylitis	0.000301	0.0101	CcSEcCtD
Aminoglutethimide—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000256	0.0086	CcSEcCtD
Aminoglutethimide—Neutropenia—Methotrexate—ankylosing spondylitis	0.000252	0.00847	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisolone—ankylosing spondylitis	0.000246	0.00828	CcSEcCtD
Aminoglutethimide—Myalgia—Triamcinolone—ankylosing spondylitis	0.000242	0.00814	CcSEcCtD
Aminoglutethimide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000241	0.00812	CcSEcCtD
Aminoglutethimide—Drowsiness—Methotrexate—ankylosing spondylitis	0.00024	0.00808	CcSEcCtD
Aminoglutethimide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000226	0.00761	CcSEcCtD
Aminoglutethimide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000226	0.0076	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000224	0.00754	CcSEcCtD
Aminoglutethimide—Myalgia—Betamethasone—ankylosing spondylitis	0.00022	0.00738	CcSEcCtD
Aminoglutethimide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00022	0.00738	CcSEcCtD
Aminoglutethimide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000216	0.00727	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000211	0.00711	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000211	0.00709	CcSEcCtD
Aminoglutethimide—Anaemia—Prednisone—ankylosing spondylitis	0.000208	0.00698	CcSEcCtD
Aminoglutethimide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000205	0.00691	CcSEcCtD
Aminoglutethimide—Tachycardia—Betamethasone—ankylosing spondylitis	0.000205	0.00691	CcSEcCtD
Aminoglutethimide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000201	0.00675	CcSEcCtD
Aminoglutethimide—Anorexia—Betamethasone—ankylosing spondylitis	0.000201	0.00675	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisolone—ankylosing spondylitis	0.0002	0.00674	CcSEcCtD
Aminoglutethimide—Hypotension—Dexamethasone—ankylosing spondylitis	0.000197	0.00662	CcSEcCtD
Aminoglutethimide—Hypotension—Betamethasone—ankylosing spondylitis	0.000197	0.00662	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000192	0.00645	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000192	0.00645	CcSEcCtD
Aminoglutethimide—Myalgia—Prednisone—ankylosing spondylitis	0.000191	0.00643	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000186	0.00625	CcSEcCtD
Aminoglutethimide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000184	0.0062	CcSEcCtD
Aminoglutethimide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000184	0.00618	CcSEcCtD
Aminoglutethimide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000183	0.00617	CcSEcCtD
Aminoglutethimide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000183	0.00615	CcSEcCtD
Aminoglutethimide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000183	0.00615	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisone—ankylosing spondylitis	0.000179	0.00602	CcSEcCtD
Aminoglutethimide—Anorexia—Prednisone—ankylosing spondylitis	0.000175	0.00588	CcSEcCtD
Aminoglutethimide—Anaemia—Methotrexate—ankylosing spondylitis	0.000173	0.00584	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000171	0.00575	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000171	0.00574	CcSEcCtD
Aminoglutethimide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000168	0.00565	CcSEcCtD
Aminoglutethimide—Urticaria—Betamethasone—ankylosing spondylitis	0.000167	0.00562	CcSEcCtD
Aminoglutethimide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000167	0.00562	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000167	0.00562	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisolone—ankylosing spondylitis	0.000167	0.00561	CcSEcCtD
Aminoglutethimide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000166	0.0056	CcSEcCtD
Aminoglutethimide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000166	0.0056	CcSEcCtD
Aminoglutethimide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000164	0.00552	CcSEcCtD
Aminoglutethimide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000164	0.00551	CcSEcCtD
Aminoglutethimide—Myalgia—Methotrexate—ankylosing spondylitis	0.00016	0.00537	CcSEcCtD
Aminoglutethimide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000159	0.00536	CcSEcCtD
Aminoglutethimide—Rash—Prednisolone—ankylosing spondylitis	0.000159	0.00535	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000159	0.00534	CcSEcCtD
Aminoglutethimide—Headache—Prednisolone—ankylosing spondylitis	0.000158	0.00532	CcSEcCtD
Aminoglutethimide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000153	0.00516	CcSEcCtD
Aminoglutethimide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000153	0.00515	CcSEcCtD
Aminoglutethimide—Nausea—Prednisolone—ankylosing spondylitis	0.00015	0.00504	CcSEcCtD
Aminoglutethimide—Pruritus—Betamethasone—ankylosing spondylitis	0.000149	0.00501	CcSEcCtD
Aminoglutethimide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000149	0.00501	CcSEcCtD
Aminoglutethimide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000147	0.00496	CcSEcCtD
Aminoglutethimide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000147	0.00495	CcSEcCtD
Aminoglutethimide—Rash—Triamcinolone—ankylosing spondylitis	0.000146	0.00492	CcSEcCtD
Aminoglutethimide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000146	0.00491	CcSEcCtD
Aminoglutethimide—Anorexia—Methotrexate—ankylosing spondylitis	0.000146	0.00491	CcSEcCtD
Aminoglutethimide—Rash—Methylprednisolone—ankylosing spondylitis	0.000146	0.00491	CcSEcCtD
Aminoglutethimide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000146	0.0049	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisone—ankylosing spondylitis	0.000146	0.0049	CcSEcCtD
Aminoglutethimide—Headache—Triamcinolone—ankylosing spondylitis	0.000145	0.00489	CcSEcCtD
Aminoglutethimide—Headache—Methylprednisolone—ankylosing spondylitis	0.000145	0.00488	CcSEcCtD
Aminoglutethimide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000145	0.00487	CcSEcCtD
Aminoglutethimide—Hypotension—Methotrexate—ankylosing spondylitis	0.000143	0.00481	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00014	0.00469	CcSEcCtD
Aminoglutethimide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000139	0.00468	CcSEcCtD
Aminoglutethimide—Dizziness—Betamethasone—ankylosing spondylitis	0.000139	0.00468	CcSEcCtD
Aminoglutethimide—Nausea—Triamcinolone—ankylosing spondylitis	0.000138	0.00463	CcSEcCtD
Aminoglutethimide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000137	0.00462	CcSEcCtD
Aminoglutethimide—Somnolence—Methotrexate—ankylosing spondylitis	0.000136	0.00458	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000135	0.00454	CcSEcCtD
Aminoglutethimide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000134	0.0045	CcSEcCtD
Aminoglutethimide—Vomiting—Betamethasone—ankylosing spondylitis	0.000134	0.0045	CcSEcCtD
Aminoglutethimide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000133	0.00448	CcSEcCtD
Aminoglutethimide—Rash—Betamethasone—ankylosing spondylitis	0.000133	0.00446	CcSEcCtD
Aminoglutethimide—Rash—Dexamethasone—ankylosing spondylitis	0.000133	0.00446	CcSEcCtD
Aminoglutethimide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000133	0.00446	CcSEcCtD
Aminoglutethimide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000133	0.00446	CcSEcCtD
Aminoglutethimide—Headache—Dexamethasone—ankylosing spondylitis	0.000132	0.00443	CcSEcCtD
Aminoglutethimide—Headache—Betamethasone—ankylosing spondylitis	0.000132	0.00443	CcSEcCtD
Aminoglutethimide—Pruritus—Prednisone—ankylosing spondylitis	0.00013	0.00436	CcSEcCtD
Aminoglutethimide—Nausea—Betamethasone—ankylosing spondylitis	0.000125	0.00421	CcSEcCtD
Aminoglutethimide—Nausea—Dexamethasone—ankylosing spondylitis	0.000125	0.00421	CcSEcCtD
Aminoglutethimide—Urticaria—Methotrexate—ankylosing spondylitis	0.000122	0.00409	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisone—ankylosing spondylitis	0.000121	0.00408	CcSEcCtD
Aminoglutethimide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000121	0.00407	CcSEcCtD
Aminoglutethimide—Vomiting—Prednisone—ankylosing spondylitis	0.000117	0.00392	CcSEcCtD
Aminoglutethimide—Rash—Prednisone—ankylosing spondylitis	0.000116	0.00389	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisone—ankylosing spondylitis	0.000115	0.00388	CcSEcCtD
Aminoglutethimide—Headache—Prednisone—ankylosing spondylitis	0.000115	0.00386	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000113	0.0038	CcSEcCtD
Aminoglutethimide—Nausea—Prednisone—ankylosing spondylitis	0.000109	0.00366	CcSEcCtD
Aminoglutethimide—Pruritus—Methotrexate—ankylosing spondylitis	0.000108	0.00365	CcSEcCtD
Aminoglutethimide—Dizziness—Methotrexate—ankylosing spondylitis	0.000101	0.00341	CcSEcCtD
Aminoglutethimide—Vomiting—Methotrexate—ankylosing spondylitis	9.74e-05	0.00328	CcSEcCtD
Aminoglutethimide—Rash—Methotrexate—ankylosing spondylitis	9.66e-05	0.00325	CcSEcCtD
Aminoglutethimide—Dermatitis—Methotrexate—ankylosing spondylitis	9.65e-05	0.00325	CcSEcCtD
Aminoglutethimide—Headache—Methotrexate—ankylosing spondylitis	9.6e-05	0.00323	CcSEcCtD
Aminoglutethimide—Nausea—Methotrexate—ankylosing spondylitis	9.1e-05	0.00306	CcSEcCtD
